A technique was developed to permit estimation of intravenous glucose tolerance and the concomitant immunoreactive insulin (IRI) response in the Geneva colony of the semi-desert rodent Acomys cahirinus.
Introduction
The occurrence of a syndrome of carbohydrate intolerance and obesity, associated with considerable congenital hyperplasia of the islets of Langerhans, has previously been described in our colony of spiny mice, Acomys cahirinus [5, 8: 10] . Earlier experiments suggested that insulin release might be impaired in the Aeomys [13] , and more recently Cameron et al. [2, 3] demonstrated that plasma IRI responses to intraperitoneally administered glucose, theophylline, isoprenaline, or cyclic AMP were lower in Acomys than in Swiss albino mice. These experiments were limited by the absence of superficial veins in this semi-desert rodent, the inability to use intravenous injections hampering detailed analysis of glucose tolerance and associated insulin responses. The present experiments were made possible by the development of a technique permitting intravenous glucose administration and serial blood sampling in the Acomys.
Materials and Methods
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weight-(25 to 35 g) matched Swiss albino mice. In addition, older Acomys at the age of 8 months (57 to 79 g) and of 21 months (57 to 100 g) were tested. In the latter group there were two diabetic animals. All animals were bred in our own laboratory and fed ad libitum until the time of experimentation between 9--10 a.m. The animals were anesthetized with sodium pentobarbital (Nembutal, Abbott Laboratories, North Chicago, Illinois, U.S.A.) 50 mg/kg injected intraperitoneally and 25 mg/kg subcutaneously. A femoral vein was exposed and, using a butterfly infusion set with a G 25 short needle (Abbott), glucose 1.5 g/kg was injected as a 20% solution during 50 to 60 sec. Injection was carried out by visualization through a binocular dissecting microscope. After the test the wound was closed with metal clips. The animals tolerated the procedure well.
Sequential blood sampling was performed by puncture of the retro-orbital venous plexus [12] using heparinized hematocrit capillary tubes before and 2, 5, 15 and 30 min after the injection of glucose. A total of 500 to 600 ~l of blood was withdrawn from each animal in one test. The individual blood samples were immediately transferred to heparinized microcentrifuge tubes, kept at 4 ~ C and, within 30 min, centrifuged for 3 min in a microcentrifuge (Greiner Electronic, Langenthal, Switzerland).
Plasma glucose was determined on 5 ~1 samples in duplicate using a glucose-oxidase method (GOD-POD kits, kindly supplied by Boehringer Mannheim, Germany).
Immunoreactive insulin (IRI) was measured on 10 91 samples in duplicate, using the charcoal separation method of Herbert et a[. [6] [7] and purified on G-25 fine Sephadex (Pharmacia, Uppsala, Sweden). Human insulin was used as standard for assay of Acomys plasma samples, since Acomys plasma dilutions were parallel to human (or pork) insulin standards (but not to rat or mouse standards), assayed with anti-pork insulin serum. Mouse insulin was used as standard for assay of albino mouse plasma samples. Insulin standards, antiserum and i~'hLinsulin were diluted in 0.2 M glyeine buffer pH 8.8, containing 0.25 g/100 ml human serum albumin (Swiss l~ed Cros% Bern, Switzerland). After incubation for 2 to 3 days at 4 ~ C, 20 ~1 of beef serum (obtained from the local abattoir) was added as a protein carrier to tubes with insulin standards, and 20 ~1 of beef serum diluted with an equal volume of glycine buffer was added to tubes with plasma samples. Antibody-bound insulin was then separated from the unbound fraction by addition of 50 ~1 of a suspension of 3.0 g charcoal (C 5260 Sigma Chem., St. Louis, Missouri, U.S.A.) and 0.25 g dextran-70 (Pharmacia, Stockholm, Sweden) in 100 ml glyeine buffer, pI-I 8.8, without human serum albumin. After a 3 rain centrifugation in the microcentrifuge the supernatants were aspirated and the charcoal pellets co~mted for 5 min in a Gamma Scintillation Spectrometer (Packard, Downers Grove, Illinois, U.S.A.). The minimal sensitivity of this assay was 0.5 ng/ml. Between 0.5 and 2.0 ng/ml, the interassay coefficient of variation was 13% and the intraassay coefficient was 80/0 . Table 1 . Glucose disposal (Kg) was significantly lower (p < 0.01) in 2 to 3 month old Acomys (1.98 j= 0.22% per rain) than in age-and weight-matched albino mice (3.08 =h 0.25% per min). Glucose disposal was decreased further in the older Acomys, although the difference between Acomys of different ages was not significant. There was, however, a significant negative correlation between glucose disposal and body weight (~'~--0.51, p<0.01) in the older Acon~ys (8 and 21 months) (Fig. 3, upper panel) . Table 1 indicates that preinfusion plasma glucose values were similar in all four normoglyeemic animal groups, but were significantly elevated (p < 0.001) in the two 21 month old diabetic Acomys. Furthermore, Table 1 indicates that preinfusion plasma It~I levels were similar in the young Acomys (1.4 4-0.2 ~g]ml) and the age and weight matched albino mice (1.7 J= 0.4 ng/ ml). 8 months old Acomys had significantly higher preinfusion plasma IRI levels (3.7 =h 0.4 ng/ml, p < 0.01), than did Acomys aged 2 to 3 months, whereas the elevation was less in the 21 month old Acomys group (2.0• ng/ml, NS). In the two diabetic animals there was no elevation of preinfusion plasma Ii~I (1.67 and 0.75 ng/ml. 2 compares the increase in plasma IRI from preinfusion levels after infusion of glucose in the different animals. The differences in the plasma II~I responses between the group of albino mice and any of the group of Acomys were most marked at 2 rain (p < 0.001) and at 5 rain (p <0.01) after glucose injection. At 15 and 30 rain the differences were smaller (p < 0.05) or not statistically significant. Plasma IRI responses are also calculated as iusuhnogenic indices, obtained by dividing the incremental plasma I1RI values integrated over 30 min follo~dng the injection of glucose by the corresponding incremental integrated plasma glucose values. Table 1 shows that the insulinogenic index for 2 to 3 month old Acomys (47.6 =}= 11.6) was significantly lower (p <0.001) than that for albino mice (137.2=}= 17.6). The insulinogenic indices were further decreased in the 8 months (11.4=J=5.8) and 21 months (26.0=k 14.5) Acomys, and the lowest indices were observed in the two diabetic Acomys (6.5 and 8.3) .
Results

Fig
Discussion
The intravenous injection procedure and a microassay for the measurement of Ii~I as described in this report enabled us to study the kinetics of insulin or glucosuric, the intravenous glucose tolerance in these animals was clearly reduced when compared to age and weight matched albino mice. Obviously, since no criteria are available, we cannot state whether or not these animals should be considered as chemical diabetics, but the finding of two diabetic animals among the 21 month old Acomys group would favour this possibility. The insulin response to the sudden elevation of blood glucose appeared to be as rapid in the young Acomys as in the albino mice, but the release during glucose tolerance tests in Acomys cahirinus. This rodent has previously been shown to be defective in insulin secretion [2] and to have an increased incidence of spontaneous diabetes [5] . Although none of the young Acomys tested were hyperglycemic Although in the Acomys the lessening of the insulin response was more pronounced soon after glucose administration, both its initial and late phases were affected. This is also shown by the markedly lower insulinogenic index values for the integrated (30 rain) insulin response, which mainly reflects the late secretion phase. In these respects the Acomys is reminiscent of human subjects with chemical diabetes or low insulin response in whom glucose tolerance is slightly to moderately reduced, while insulin response to glucose is markedly diminished (with emphasis on the initial response) [4] . It must be borne in mind, however, that the glucose infusions presented in this report were performed while the animals were under Nembutal anesthesia, a condition which has been shown to affect both glucose tolerance and insulin secretion [1] . Therefore, whether the glucose and insulin data given here do represent the actual in vivo situation in the animals must remain an open question.
Acomys develop moderate obesity with increasing age [5] , and obesity is known to be accompanied by enhanced insulin secretion in many animal species [3] and in man [9] . In the Acomys of older age groups (8 and 21 months) the level of circulating insulin before glucose administration was indeed higher than in the younger and leaner animals. However, no enhancement of the insulin response to glucose injection could be observed in these obese Acomys. There was no correlation between the insulinogenic index and body weight in the older animals (Fig. 3 , lower panel) in spite of the wide range in weights (57 to 100 g). Nevertheless, the lower insulin response to glucose demonstrated in the older Acomys suggests that B-cell responsiveness decreases with age. This possibly masks the expected increase in insulin response with obesity. Furthermore, the B-cell defect presumably inherent in the Acomys may limit the free expression of obesity as a stimulating factor for insulin secretion. A similar situation appears to exist in mice of the obese hyperglycemic strain DBM in which the more hyperglycemic animals demonstrate higher basal (fasting) plasma insulin levels but smaller insulin responses to glucose [3] . Since obesity is associated with insulin resistance [11] one would expect deterioration of glucose tolerance in the Acomys whose insulin secretion was not enhanced by obesity. Indeed, as shown in Fig. 3 , a significant negative correlation was found between glucose tolerance (Kg) and body weight in the higher age group of Acomys, where obesity is more apparent. Since glucose tolerance of 21 month old animals (the diabetic animals excluded) was not significantly different from that of 8 months old Acomys, it is probable that this lesser glucose tolerance may be more closely related to obesity than to ageing. The eventual development of marked or severe glucose intolerance in Acomys may depend on the balance between the gradual reduction in insulin response with age, the degree of enhancement of the islet function induced by obesity, and the severity of resistance to insulin that may accompany this state.
